Samuel George A. III bought LCTX
February 11, 2025 · Form 4 insider transaction
Samuel George A. III bought 6,076 shares of Lineage Cell Therapeutics, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
6,076
Price
N/A
Total value
N/A
InsiderSamuel George A. III
RoleOfficer
SecurityCommon Shares
Transaction codeM: Option exercise
Transaction dateFebruary 11, 2025
Filing dateFebruary 12, 2025
Shares owned after28,260
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares earned by the Reporting Person as a result of the vesting of a portion of Restricted Stock Units ("RSUs") granted to the Reporting Person on February 11, 2022. RSUs convert into common shares on a one-for-one basis.; Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date hereof or shares that may be acquired upon the exercise of certain stock options.